| Financial Year |
March 31 2023 |
| Monetary Funds |
1,593,604,786.64 |
| Held-for-trading Financial Assets |
3,125,153.16 |
| Notes Receivable |
7,254,449.06 |
| Accounts Receivable |
368,546,636.60 |
| Advances to Suppliers |
264,345,503.95 |
| Other Receivables |
27,444,540.84 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,487,020,081.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
886,740,528.07 |
| Total Current Assets |
5,651,298,859.32 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
43,987,914.97 |
| Investment Properties |
11,858,392.02 |
| Fixed Assetes |
1,342,157,123.25 |
| Under-construction Projects |
173,302,768.85 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
308,554,977.31 |
| R&D expenses |
5,482,616.98 |
| Goodwill |
593,859.19 |
| Long-Term Deferred and Prepaid Expenses |
549,999.75 |
| Deferred Income Tax Assets |
33,324,110.30 |
| Other Non-Current Assets |
11,572,118.31 |
| Sub-Total of Non-Current Assets |
1,986,040,098.25 |
| Total Assets |
7,637,338,957.57 |
| Short-Term Loans |
2,630,102,746.80 |
| Trading Financial liabilities |
736,582.96 |
| Notes Payable |
-- |
| Accounts Payable |
36,761,294.98 |
| Accounts Received In Advance |
154,078.23 |
| Employee Compensation Payable |
103,783,819.00 |
| Taxes Payable |
40,181,086.31 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
79,849,422.45 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
23,352,750.18 |
| Other Current Liabilities |
24,420,637.82 |
| Sub-Total of Current Liabilities |
3,312,102,614.23 |
| Long-term Loans |
770,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
69,120,484.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
15,542,131.25 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
962,853,130.89 |
| Total Liabilities |
4,274,955,745.12 |
| Paid-In Capital(Or Share Stock) |
532,773,991.00 |
| Capital Surplus |
1,021,555,136.23 |
| Surplus Reserve |
142,330,286.70 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,654,373,814.94 |
| Minority Stockholder's Interest |
52,216,662.61 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,310,166,549.84 |
| Owner's Equity（Stockholder's Equity） |
3,362,383,212.45 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,637,338,957.57 |
